CompaniesSanofi-Synthelabo

Sanofi-Synthelabo

defunct

About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (50)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

34,672

By Phase

PHASE1: 4PHASE1/PHASE2: 6PHASE4: 9PHASE2: 22PHASE3: 5PHASE2/PHASE3: 1NA: 1

By Status

COMPLETED: 38TERMINATED: 9UNKNOWN: 2ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline49 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Today

NCT00224679

APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence

Phase: Phase 3

Role: Collaborator

Start: Mar 31, 1997

Completion: Mar 31, 1999

NCT00007683

Warfarin and Antiplatelet Therapy in Chronic Heart Failure

Phase: Phase 3

Role: Collaborator

Start: Oct 31, 1998

Completion: Dec 31, 2004

NCT00007683

NCT00204061

Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis

Phase: Phase 4

Role: Collaborator

Start: Jan 31, 2001

Completion: Jun 30, 2005

NCT01107548

Prevention of Stroke and Dementia in Primary Care

Phase: N/A

Role: Collaborator

Start: Jan 31, 2001

Completion: Mar 31, 2010

NCT01107548

NCT00221637

Efficacy of Valproate in Peripheral Neuropathic Pain

Phase: Phase 2/3

Role: Collaborator

Start: Mar 31, 2002

Completion: Jul 31, 2005

NCT00210249

Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment

Phase: N/A

Role: Collaborator

Start: Sep 30, 2002

Completion: Sep 30, 2008

NCT00210249

NCT00494468

Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children

Phase: Phase 1/2

Role: Collaborator

Start: Oct 31, 2002

Completion: Mar 31, 2004

NCT00123851

Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer

Phase: Phase 2

Role: Collaborator

Start: Mar 31, 2003

Completion: Aug 31, 2006

NCT00169195

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

Phase: Phase 2

Role: Collaborator

Start: Apr 30, 2003

Completion: Nov 30, 2012

NCT00169195

NCT01016639

Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer

Phase: Phase 1/2

Role: Collaborator

Start: Jun 30, 2003

Completion: Jul 31, 2009

NCT01016639

NCT01465646

Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 100 μg/ 75 μg Tablets

Phase: Phase 1

Role: Collaborator

Start: Jun 30, 2003

Completion: Dec 31, 2003

NCT00338988

Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma

Phase: Phase 2

Role: Collaborator

Start: Aug 31, 2003

Completion: May 31, 2009

NCT00338988

NCT01465633

Phase: Phase 1

Role: Collaborator

Start: Aug 31, 2003

Completion: Nov 30, 2003

NCT00124267

Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria

Phase: Phase 3

Role: Collaborator

Start: Sep 30, 2003

Completion: Jan 31, 2004

NCT01136226

Evaluate Recovery of Testosterone for Patients Using Eligard

Phase: Phase 4

Role: Collaborator

Start: Oct 31, 2003

Completion: Jun 30, 2009

NCT01136226

NCT00075205

Rimonabant to Reduce Alcohol Consumption

Phase: Phase 2

Role: Collaborator

Start: Dec 31, 2003

Completion: Mar 15, 2007

NCT00186277

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

Phase: Phase 2

Role: Collaborator

Start: Dec 31, 2003

Completion: Dec 31, 2006

NCT00525785

Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)

Phase: Phase 2

Role: Collaborator

Start: Jan 31, 2004

Completion: Jan 31, 2016

NCT00525785

NCT00353145

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Phase: Phase 2

Role: Collaborator

Start: Feb 29, 2004

Completion: Jan 31, 2010

NCT00353145

NCT00152737

Objective Evaluation of Proximal Ischemia

Phase: N/A

Role: Collaborator

Start: Mar 31, 2004

Completion: Jul 31, 2008

NCT00064649

Minimally Invasive Surgical Therapy for BPH

Phase: Phase 3

Role: Collaborator

Start: Apr 30, 2004

Completion: Jun 30, 2006

NCT00142467

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Phase: Phase 2

Role: Collaborator

Start: Apr 30, 2004

Completion: Jun 30, 2011

NCT00142467

NCT00193128

Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer

Phase: Phase 1/2

Role: Collaborator

Start: Apr 30, 2004

Completion: Jan 31, 2009

NCT00217282

Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer

Phase: Phase 2

Role: Collaborator

Start: Jun 30, 2004

Completion: Mar 31, 2008

NCT00242190

Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer

Phase: Phase 1/2

Role: Collaborator

Start: Jun 30, 2004

Completion: Feb 28, 2010

NCT00242190

NCT00210184

Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer

Phase: Phase 2

Role: Collaborator

Start: Jul 21, 2004

Completion: Apr 30, 2010

NCT00210184

NCT00526110

Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients

Phase: Phase 1/2

Role: Collaborator

Start: Aug 31, 2004

Completion: Jun 30, 2015

NCT00526110

NCT00193609

Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

Phase: Phase 2

Role: Collaborator

Start: Sep 30, 2004

Completion: Jan 31, 2009

NCT00101075

Title XELOX FOR SALIVARY GLAND CANCERS

Phase: Phase 2

Role: Collaborator

Start: Oct 31, 2004

Completion: Mar 31, 2008

NCT00256321

Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma

Phase: Phase 2

Role: Collaborator

Start: Oct 31, 2004

Completion: Aug 31, 2007

NCT00297141

Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

Phase: Phase 2

Role: Collaborator

Start: Oct 31, 2004

Completion: Dec 31, 2013

NCT00297141

NCT00354887

Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater

Phase: Phase 2

Role: Collaborator

Start: Nov 30, 2004

Completion: Nov 30, 2009

NCT03159143

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Phase: Phase 2

Role: Collaborator

Start: Dec 17, 2004

Completion: Dec 2, 2009

NCT00142480

Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

Phase: Phase 2

Role: Collaborator

Start: Dec 31, 2004

Completion: Apr 30, 2011

NCT00142480

NCT00116506

Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer

Phase: Phase 2

Role: Collaborator

Start: Jan 31, 2005

Completion: Jul 31, 2007

NCT00145418

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

Phase: Phase 2

Role: Collaborator

Start: Feb 28, 2005

Completion: Mar 31, 2010

NCT00316433

Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer

Phase: Phase 2

Role: Collaborator

Start: Feb 28, 2005

Completion: Jan 31, 2007

NCT00156533

Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing

Phase: Phase 4

Role: Collaborator

Start: Mar 31, 2005

Completion: Feb 29, 2008

NCT00190307

STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery

Phase: Phase 4

Role: Collaborator

Start: Jun 30, 2005

Completion: Dec 31, 2009

NCT00240097

Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)

Phase: Phase 2

Role: Collaborator

Start: Jun 30, 2005

Completion: Jun 30, 2010

NCT00343876

Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial

Phase: Phase 4

Role: Collaborator

Start: Jul 31, 2005

Completion: Nov 30, 2006

NCT00418093

Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma

Phase: Phase 2

Role: Collaborator

Start: Sep 30, 2006

Completion: Oct 31, 2011

NCT00413361

The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS

Phase: Phase 4

Role: Collaborator

Start: Jun 30, 2007

Completion: Jan 31, 2011

NCT00977938

The Dual Antiplatelet Therapy Study (DAPT Study)

Phase: Phase 4

Role: Collaborator

Start: Oct 31, 2009

Completion: Jun 30, 2014

NCT01284959

Different Safety Profile of Risperidone and Paliperidone Extended-release

Phase: Phase 4

Role: Collaborator

Start: Jun 30, 2010

Completion: Dec 31, 2010

NCT01504620

Performance Evaluation of Blood Glucose Monitoring Systems

Phase: Phase 4

Role: Collaborator

Start: Jan 31, 2011

Completion: Jun 30, 2011

NCT02049203

Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis

Phase: Phase 1

Role: Collaborator

Start: Jan 31, 2014

Completion: Mar 31, 2015

NCT02522572

Quantitating the Impact of Plerixafor

Phase: Phase 1/2

Role: Collaborator

Start: Aug 31, 2015

Completion: Oct 31, 2020

NCT02522572

NCT04975152

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Phase: Phase 1

Role: Collaborator

Start: Oct 22, 2021

Completion: Mar 31, 2028

NCT04975152

Hover over trial bars to see details

Recent Trials

NCT04975152Collaborator

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

PHASE1Active, not recruiting

36 participants

Started: Oct 22, 2021 · Completed: Mar 31, 2028

NCT02522572Collaborator

Quantitating the Impact of Plerixafor

PHASE1/PHASE2Unknown

12 participants

Started: Aug 31, 2015 · Completed: Oct 31, 2020

NCT02049203Collaborator

Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis

PHASE1Completed

44 participants

Started: Jan 31, 2014 · Completed: Mar 31, 2015

NCT01504620Collaborator

Performance Evaluation of Blood Glucose Monitoring Systems

PHASE4Completed

106 participants

Started: Jan 31, 2011 · Completed: Jun 30, 2011

NCT01284959Collaborator

Different Safety Profile of Risperidone and Paliperidone Extended-release

PHASE4Completed

34 participants

Started: Jun 30, 2010 · Completed: Dec 31, 2010

View all 50 trials →

Related Companies

Aventis

merged